دورية أكاديمية

Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial cancer: a systematic review and Meta-analysis.
المؤلفون: Tsuboi I; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan.; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Matsukawa A; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Jikei University School of Medicine, Tokyo, Japan., Kardoust Parizi M; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Klemm J; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schulz RJ; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Cadenar A; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Unit of Oncologic Minimally Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy., Mancon S; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Chiujdea S; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Spitalul Clinic Judetean Murures, University of Medicine, Science, and Technology of Targu Mures, Pharmacy, Mures, Romania., Fazekas T; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Semmelweis University, Budapest, Hungary., Miszczyk M; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland., Laukhtina E; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Kawada T; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Katayama S; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Iwata T; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Bekku K; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Wada K; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria.; Department of Urology, Shimane University Faculty of Medicine, Shimane, Japan., Gontero P; Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, Turin, Italy., Rouprêt M; Sorbonne University, AP-HP, Pitie-Salpetriere Hospital, GRC 5 Predictive Onco-Uro, Urology, PARIS, F- 75013, France., Teoh J; Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China., Singla N; Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Park 213, Baltimore, MD, 21287, USA., Araki M; Department of Urology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan., Shariat SF; Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Vienna, A-1090, Austria. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Semmelweis University, Budapest, Hungary. shahrokh.shariat@meduniwien.ac.at.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Weill Cornell Medical College, New York, NY, USA. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia, Czechia. shahrokh.shariat@meduniwien.ac.at.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan. shahrokh.shariat@meduniwien.ac.at.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.; Research Center for Evidence Medicine, Urology Department Tabriz University of Medical Sciences, Tabriz, Iran. shahrokh.shariat@meduniwien.ac.at.
المصدر: World journal of urology [World J Urol] 2024 Aug 20; Vol. 42 (1), pp. 488. Date of Electronic Publication: 2024 Aug 20.
نوع المنشور: Systematic Review; Journal Article; Meta-Analysis
اللغة: English
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Berlin ; New York] : Springer International, 1983-
مواضيع طبية MeSH: Nephroureterectomy*/methods , Ureteral Neoplasms*/surgery , Neoplasm Recurrence, Local*/epidemiology , Carcinoma, Transitional Cell*/surgery , Carcinoma, Transitional Cell*/pathology , Kidney Neoplasms*/surgery , Kidney Neoplasms*/pathology , Urinary Bladder Neoplasms*/surgery , Urinary Bladder Neoplasms*/pathology, Humans ; Ureter/surgery
مستخلص: Context: Radical nephroureterectomy (RNU) with bladder cuff resection is the standard treatment in patients with high-risk upper tract urothelial cancer (UTUC). However, it is unclear which specific surgical technique may lead to improve oncological outcomes in term of intravesical recurrence (IVR) in patients with UTUC.
Objective: To evaluate the efficacy of surgical techniques and approaches of RNU in reducing IVR in UTUC patients.
Evidence Acquisition: Three databases were queried in January 2024 for studies analyzing UTUC patients who underwent RNU. The primary outcome of interest was the rate of IVR among various types of surgical techniques and approaches of RNU.
Evidence Synthesis: Thirty-one studies, comprising 1 randomized controlled trial and 1 prospective study, were included for a systematic review and meta-analysis. The rate of IVR was significantly lower in RNU patients who had an early ligation (EL) of the ureter compared to those who did not (HR: 0.64, 95% CI: 0.44-0.94, p = 0.02). Laparoscopic RNU significantly increased the IVR compared to open RNU (HR: 1.28, 95% CI: 1.06-1.54, p < 0.001). Intravesical bladder cuff removal significantly reduced the IVR compared to both extravesical and transurethral bladder cuff removal (HR: 0.65, 95% CI: 0.51-0.83, p = 0.02 and HR: 1.64, 95% CI: 1.15-2.34, p = 0.006, respectively).
Conclusions: EL of the affected upper tract system, ureteral management, open RNU, and intravesical bladder cuff removal seem to yield the lowest IVR rate in patients with UTUC. Well-designed prospective studies are needed to conclusively elucidate the optimal surgical technique in the setting of single post-operative intravesical chemotherapy.
(© 2024. The Author(s).)
References: Eur J Cancer. 2009 Dec;45(18):3291-7. (PMID: 19615885)
World J Urol. 2009 Feb;27(1):81-8. (PMID: 19020880)
Jpn J Clin Oncol. 2017 Sep 01;47(9):870-875. (PMID: 28903527)
World J Surg Oncol. 2021 Apr 21;19(1):129. (PMID: 33882936)
Cancer Res Treat. 2019 Jul;51(3):963-972. (PMID: 30322230)
Eur Urol. 2019 Mar;75(3):358-367. (PMID: 30580902)
Front Oncol. 2021 Oct 04;11:731460. (PMID: 34671556)
Cancer Res Treat. 2021 Jul;53(3):795-802. (PMID: 33421984)
World J Urol. 2023 Mar;41(3):757-765. (PMID: 36692533)
Eur Urol. 2014 Mar;65(3):650-8. (PMID: 24070577)
J Urol. 2021 Sep;206(3):568-576. (PMID: 33881931)
Cancer. 2009 Mar 15;115(6):1224-33. (PMID: 19156917)
Int Braz J Urol. 2023 Jul-Aug;49(4):469-478. (PMID: 37267612)
Urol Int. 2017;98(3):312-319. (PMID: 27842318)
World J Urol. 2013 Feb;31(1):61-8. (PMID: 23053211)
Urol Int. 2014;92(1):68-73. (PMID: 24051653)
Scand J Urol. 2020 Feb;54(1):58-64. (PMID: 31942812)
J Clin Oncol. 2013 Apr 10;31(11):1422-7. (PMID: 23460707)
Front Oncol. 2021 Oct 07;11:730114. (PMID: 34692504)
Cancers (Basel). 2023 Feb 23;15(5):. (PMID: 36900201)
Int J Surg. 2020 Mar;75:165-173. (PMID: 31978650)
Ann Surg Oncol. 2023 Jun;30(6):3805-3816. (PMID: 36879036)
BMC Med Res Methodol. 2021 Jun 1;21(1):111. (PMID: 34074267)
Oncogene. 2001 Aug 9;20(35):4910-5. (PMID: 11521204)
Clin Genitourin Cancer. 2017 Dec;15(6):e1055-e1061. (PMID: 28802888)
BMJ. 2016 Oct 12;355:i4919. (PMID: 27733354)
Urol Oncol. 2014 Aug;32(6):839-45. (PMID: 24856978)
Chin Med J (Engl). 2012 Nov;125(21):3821-6. (PMID: 23106881)
Eur Urol. 2014 Jan;65(1):210-7. (PMID: 22579047)
Asia Pac J Clin Oncol. 2023 Feb;19(1):71-78. (PMID: 35404494)
Ann Surg Oncol. 2021 Jan;28(1):465-473. (PMID: 32840743)
Front Surg. 2022 Sep 01;9:934355. (PMID: 36117820)
Int J Clin Oncol. 2018 Aug;23(4):726-733. (PMID: 29435873)
Cent European J Urol. 2022;75(3):257-264. (PMID: 36381160)
Front Oncol. 2022 Dec 01;12:1031774. (PMID: 36530967)
Int J Urol. 2016 May;23(5):378-84. (PMID: 26780531)
BMJ. 2011 Oct 18;343:d5928. (PMID: 22008217)
Eur Urol. 2010 Nov;58(5):645-51. (PMID: 20724065)
Eur Urol. 2011 Oct;60(4):703-10. (PMID: 21684068)
BMC Surg. 2017 Jan 17;17(1):8. (PMID: 28095848)
Ann Surg Oncol. 2019 Oct;26(11):3774-3781. (PMID: 31313043)
Eur Urol. 2015 Jun;67(6):1122-1133. (PMID: 25488681)
Int J Urol. 2014 Apr;21(4):366-9. (PMID: 24118071)
World J Urol. 2012 Apr;30(2):271-5. (PMID: 21805177)
Front Oncol. 2022 Jan 13;11:766576. (PMID: 35096575)
World J Urol. 2020 Apr;38(4):845-852. (PMID: 31773242)
Int J Urol. 2021 Feb;28(2):208-214. (PMID: 33283389)
فهرسة مساهمة: Keywords: Intravesical recurrence; Radical nephroureterectomy; Upper tract urinary cancer
تواريخ الأحداث: Date Created: 20240820 Date Completed: 20240820 Latest Revision: 20240823
رمز التحديث: 20240823
مُعرف محوري في PubMed: PMC11335797
DOI: 10.1007/s00345-024-05185-w
PMID: 39162743
قاعدة البيانات: MEDLINE
الوصف
تدمد:1433-8726
DOI:10.1007/s00345-024-05185-w